CD69 anticorps (AA 1-199)

N° du produit ABIN7868359

Cet anticorps anti-CD69 Polyclonal Lapin (ABIN7868359) détecte spécifiquement CD69 dans WB et ELISA. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour CD69 anticorps (AA 1-199) (ABIN7868359)

Antigène: CD69

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CD69 est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-CD69 anticorps

Épitope: AA 1-199

Fonction: CD69 Antibody

Purification: Immunogen affinity purified

Immunogène: E.coli-derived human CD69 recombinant protein (Position: M1-K199) was used as the immunogen for the CD69 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the CD69 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the CD69 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur CD69

Antigène: CD69

Autre désignation: CD69

Sujet: CD69 antibody detects Early activation antigen CD69, encoded by the CD69 gene on chromosome 12p13.31. CD69 antibody is widely used in immunology research as CD69 is one of the earliest markers of lymphocyte activation. CD69 is a type II transmembrane C-type lectin receptor expressed on T cells, B cells, NK cells, and other leukocytes shortly after stimulation. It functions in immune regulation, signaling, and tissue retention of lymphocytes, making it a key marker of immune activation and inflammation.

Structurally, CD69 is a ~28-32 kDa disulfide-linked homodimer composed of an extracellular C-type lectin-like domain, a transmembrane region, and a short cytoplasmic tail. The lectin domain mediates protein interactions, while the transmembrane region associates with signaling molecules. CD69 is rapidly upregulated at the cell surface following antigen recognition or cytokine stimulation, making it a sensitive marker of early activation.

Functionally, CD69 regulates immune cell proliferation, cytokine production, and migration. It modulates signaling pathways downstream of the T cell receptor and integrins. Importantly, CD69 binds sphingosine-1-phosphate receptor 1 (S1PR1) and promotes its internalization, reducing lymphocyte egress from lymphoid organs. Through this mechanism, CD69 contributes to tissue retention of immune cells during immune responses. Researchers use CD69 antibody to study lymphocyte activation, tissue homing, and inflammation.

Clinically, CD69 is an important biomarker of immune activation in infection, autoimmune disease, and cancer. Elevated CD69 expression is associated with autoimmune pathologies such as lupus and rheumatoid arthritis. It has also been used to monitor immune responses in HIV infection and cancer immunotherapy. In oncology, tumor-infiltrating lymphocytes expressing CD69 often indicate active immune engagement. NSJ Bioreagents provides CD69 antibody for immunology, oncology, and translational research applications.

Experimentally, CD69 antibody is widely used in flow cytometry to monitor lymphocyte activation, in immunohistochemistry to study tissue infiltration, and in western blotting to confirm expression. Functional assays using CD69 antibody help evaluate lymphocyte responses to antigenic or cytokine stimuli.

UniProt: Q07108